The beauty conglomerate has joined with biotechnology and pharmaceutical company Serpin Pharma for ingredient research.

Shares of Estee Lauder Cos. Cl A EL shed 2.01% to $73.28 Wednesday, on what proved to be an all-around mixed trading session ...

Under Armour has tapped Liz Bacelar, former executive director of global tech innovation at Estée Lauder, as its new head of ...

Bell Asset Management, an investment management company, released its Q4 2024 “Bell Global Equities Fund” investor letter. A ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 ...

We came across a bullish thesis on The Estée Lauder Companies Inc. (EL) on Substack by Alexandru Dragut. In this article, we ...

Would you like to be notified of the latest news and updates on the stock market?

The move forms part of ELC’s newly unveiled Beauty Reimagined strategic vision, which aims to help the company return to ...

Estee Lauder (EL) announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory ...

A beauty editor reviews Estée Lauder’s new Double Wear Stay-In-Place Concealer, testing its long-wear capabilities, hydrating ...

Estée Lauder shares tumbled 17% Tuesday after the cosmetics giant reported a surprise loss and warned about current-quarter ...